Purchase Order 75N95024P00362
Award Date
6/28/24
Potential Completion Date
6/27/25
Potential Value
$27K
Funding Federal Agency
National Center for Advancing Translational Sciences
Contracting Federal Agency
National Institute on Drug Abuse
Awardee
Caerus US 1 Inc.
Ultimate Awardee
Not listed
NAICS Category
513210 - Software Publishers
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
New York, NY 10119, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Clinger Cohen Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The National Center for Advancing Translational Sciences (NCATS), a civilian agency within the U.S. Department of Health and Human Services, awarded a $85,303.20 firm fixed-price purchase order to Clarivate Analytics (Us) LLC for an annual subscription to the Clarivate Integrity database and associated information products. This non-competitive sole-source award provides NCATS with access to Clarivate's proprietary scientific literature databases, analytics platforms, and program evaluation...
The National Center for Advancing Translational Sciences (NCATS), a civilian agency within the Department of Health and Human Services, awarded a $87,500.00 firm-fixed-price purchase order to Chemaxon LLC for a 5-year renewal and support of cheminformatics software licenses. The software, which includes products like JChem Oracle Cartridge, Marvin JS, and Instant JChem Enterprise, supports NCATS' initiatives in biotechnology and pharmaceutical research, such as the Preclinical Screening Platform...
This purchase order was awarded by the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH), to Clarivate Analytics (Us) LLC. The contract provides the NCATS Chemical Genomics Center with a one-year subscription to Clarivate's Cortellis Drug Discovery Intelligence and Off-X Translational Safety/Toxicology databases, with two one-year option periods. The total potential contract value is $244,381.61. The contract was awarded on a...
This federal contract award, worth $38,745.00, was issued by the National Cancer Institute (NCI), a component of the Department of Health and Human Services, to Caerus US 1 Inc., operating as Citeline. The contract provides TRIALTROVE licenses to the NCI, which offers pharmaceutical information, drug development data, and market intelligence to support the agency's healthcare research and drug development initiatives. The contract is a firm fixed-price purchase order with an ultimate...
This federal contract award was issued by the National Center for Advancing Translational Sciences (NCATS), which is part of the National Institutes of Health (NIH) under the Department of Health and Human Services (HHS). The contract, valued at $42,500.00, was awarded to Adeptia Inc. for the provision of Adeptia Connect ETL (Extract, Transform, Load) data mapping software licenses and support services. The original solicitation was a non-competitive combined synopsis/solicitation for commercial...
The National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS) awarded a $240,000.00 firm fixed-price purchase order to Chemogenics Biopharma, LLC, a for-profit limited liability company, for custom synthesis and bioanalytical services to support NCATS' internal projects focused on developing small molecule inhibitors of physiological small molecule methyltransferases. The 12-month contract is not set aside and is awarded under FAR Part 13 simplified...
This is a non-competitive contract award by the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH), to Clarivate Analytics (US) LLC for Clarivate's "Drug Research Advisor" and "Key Pathway Advisor" software tools. The contract is a firm fixed-price purchase order with a ceiling value of $40,117.55. The contract was awarded without any set-aside designation as Clarivate was determined to be the sole source provider...
The National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH), awarded a $141,500 firm-fixed-price purchase order to Chemdiv, Inc. for the acquisition of an 11,000 compound methyltransferase library. This non-competitive award was made under simplified acquisition procedures without a set-aside designation. The contract required delivery of the compound library within 8 weeks. Chemdiv, Inc. is a for-profit organization providing drug...
The Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences awarded a $24,512.25 firm fixed-price purchase order to Life Technologies Corporation of Carlsbad, California. As the prime contractor, Life Technologies will provide products or services to NIH NCATS between August 31 and October 1, 2023. The award is not associated with a multiple award contract vehicle. No subcontractors or set aside designations were indicated....
The National Institutes of Health's National Center for Advancing Translational Sciences awarded a $1.2 million firm fixed price delivery order to Palantir Technologies Inc. to provide user access to NCATS' Collaborative Scientific Platform. As described in Task Order No. 1, Palantir will support NCATS' mission of accelerating the development and delivery of new drugs, diagnostics, and medical technologies by enabling access to its collaborative platform in accordance with the terms of the...